Immunoclin (Immunoclin) Change In Payables And Accrued Expense : $1.10 Mil (TTM As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Change In Payables And Accrued Expense?

Immunoclin's Change In Payables And Accrued Expense for the quarter that ended in Oct. 2014 was $0.47 Mil. It means Immunoclin's Accounts Payable & Accrued Expense increased by $0.47 Mil from Jul. 2014 to Oct. 2014 .

Immunoclin's Change In Payables And Accrued Expense for the fiscal year that ended in Jan. 2014 was $0.28 Mil. It means Immunoclin's Accounts Payable & Accrued Expense increased by $0.28 Mil from Jan. 2013 to Jan. 2014 .

Immunoclin Change In Payables And Accrued Expense Historical Data

The historical data trend for Immunoclin's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Change In Payables And Accrued Expense Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Change In Payables And Accrued Expense

0.05

0.08

0.28

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Change In Payables And Accrued Expense	Get a 7-Day Free Trial									0.01	-	0.27	0.35	0.47

Immunoclin Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.10 Mil.

Immunoclin Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Immunoclin's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines